Nordic Nanovector to Present at Biotech Showcase 2017
Oslo, Norway, 4 January 2017Nordic Nanovector ASA (OSE: NANO), a biotechnology company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology, announces today that Chief Operating Officer (COO), Marco Renoldi, MD, will present at the 9th Annual Biotech Showcase™ on Monday, January 9th 2017, San Francisco, US. The investor and partnering conference attracts pharmaceutical executives from around the world focused on investment and business development opportunities in the life sciences industry. COO, Marco Renoldi, MD, will present an